Completely updated and revised, the 28th edition of this best-selling reference provides instant access to the latest recommendations for treatment of infectious diseases in children.
For each disease, the authors provide a commentary to help select the best of all antimicrobial choices. Drug descriptions cover all antimicrobial agents available today and include complete information about dosing regimens.
TOPICS INCLUDE
- Antimicrobial Therapy by Clinical Syndromes
- Antimicrobial Therapy for Neonates
- Choosing Among
- Antibiotics
- Antifungal Agents
- Antiviral Agents
- Antiparasitic Agents
- Oral Step-down Therapy for Serious Infections
- Prevention of Symptomatic Infection
- Approach to Antibiotic Allergies
- Antibiotic Stewardship
New in the 28th Edition
- Updated recommendations on acute hematogenous osteomyelitis, based on newly published guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America, including information on a decrease in the incidence of MRSA infections, allowing the recommendation of cefazolin, again, in empiric therapy for most pediatric bone infections
- Updated recommendations on influenza treatment and prophylaxis, reflecting American Academy of Pediatrics guidance for 2021–2022
- Ceftazidime/avibactam now preferred over fluoroquinolones for treatment of Klebsiella pneumoniae carbapenemase–producing enteric bacilli, if susceptible
- Cefiderocol, a new iron-binding siderophore cephalosporin class, recently approved in adults for treatment of many drug-resistant pathogens, particularly Acinetobacter, Stenotrophomonas, and Pseudomonas; under study in children
- New dosing for posaconazole suspension formulation
- New approaches to mucormycosis
- Added baloxavir for children 12+ years old
